Evidence map›Paper›PMID 40769900›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Paraneoplastic Inflammatory Myositis False-positive for Anti-aminoacyl-tRNA synthetase Antibody Successfully Ameliorated by Immunosuppressive Therapy.

Masahiro Akiyama, Yoshiyuki Arinuma, Yosuke Nakamura, Takaya Utsunomiya, Akisato Nishigaki, Rufuto Ando, Ryoshin Mizuno, Asako Mitsui, Naohiro Sugitani, Yuhei Ito and 1 more

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masahiro AkiyamaCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Yoshiyuki ArinumaCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Yosuke NakamuraCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Takaya UtsunomiyaDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Akisato NishigakiDepartment of Neurology, Mie University Graduate School of Medicine, Japan.
Rufuto AndoCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Ryoshin MizunoCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Asako MitsuiCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Naohiro SugitaniCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Yuhei ItoCenter for Rheumatic Diseases, Mie University Hospital, Japan.
Ayako NakajimaCenter for Rheumatic Diseases, Mie University Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a 60-year-old woman with anti-aminoacyl-tRNA synthetase (ARS) antibody-false-positive paraneoplastic polymyositis complicated with ovarian carcinoma, which was promptly ameliorated by immunosuppressive therapy, including glucocorticoids (GCs), before treatment against malignancy. The patient was admitted to our hospital because of rapidly progressive muscular weakness of the neck and both limbs over three weeks. Upon a detailed examination, the patient tested positive for anti-ARS antibodies by an enzyme-linked immunosorbent assay (ELISA), which were later determined to be false positives, as confirmed by immunoblotting and immunoprecipitation. She was strongly suspected to have ovarian carcinoma and pulmonary metastasis. A biopsy of her muscle revealed myositis, mainly with CD68

Indexed as

Amino Acyl-tRNA SynthetasesAutoantibodiesImmunosuppressive AgentsMyositisParaneoplastic SyndromesPolymyositisFalse Positive ReactionsFemaleGlucocorticoidsHumansMiddle AgedOvarian NeoplasmsAmino Acyl-tRNA SynthetasesAutoantibodiesGlucocorticoidsImmunosuppressive Agentsanti-aminoacyl-tRNA synthetase antibodiesmalignancymyositis-specific antibodyparaneoplastic syndromepolymyositis

Identifiers

PMID40769900
PMCPMC13019017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.